z-logo
open-access-imgOpen Access
Cryptic Regulation of Vasotocin Neuronal Activity but Not Anatomy by Sex Steroids and Social Stimuli in Opportunistic Desert Finches
Author(s) -
David Kabelik,
Jenilee A. Morrison,
James L. Goodson
Publication year - 2010
Publication title -
brain behavior and evolution
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 77
eISSN - 1421-9743
pISSN - 0006-8977
DOI - 10.1159/000297522
Subject(s) - vasotocin , colocalization , biology , taeniopygia , aromatase , neuropeptide , medicine , endocrinology , stria terminalis , vasopressin , flutamide , immediate early gene , songbird , neuroscience , zebra finch , courtship display , courtship , androgen receptor , hypothalamus , receptor , zoology , ecology , gene expression , prostate cancer , cancer , genetics , breast cancer , gene , biochemistry
In most vertebrate species, the production of vasotocin (VT; non-mammals) and vasopressin (VP; mammals) in the medial bed nucleus of the stria terminalis (BSTm) waxes and wanes with seasonal reproductive state; however, opportunistically breeding species might need to maintain high levels of this behaviorally relevant neuropeptide year-round in anticipation of unpredictable breeding opportunities. We here provide support for this hypothesis and demonstrate that these neurons are instead regulated 'cryptically' via hormonal regulation of their activity levels, which may be rapidly modified to adjust VT signaling. First, we show that combined treatment of male and female zebra finches (Estrildidae: Taeniopygia guttata) with the androgen receptor antagonist flutamide and the aromatase inhibitor 1,4,6-androstatriene-3,17-dione does not alter the expression of VT immunoreactivity within the BSTm; however, both hormonal treatment and social housing environment (same-sex versus mixed-sex) alter VT colocalization with the immediate early gene product Fos (a proxy marker of neural activation) in the BSTm. In a second experiment, manipulations of estradiol (E2) levels with the aromatase inhibitor letrozole (LET) or subcutaneous E2 implants failed to alter colocalization, suggesting that the colocalization effects in experiment 1 were solely androgenic. LET treatment also did not affect VT immunoreactivity in a manner reversible by E2 treatment. Finally, comparisons of VT immunoreactivity in breeding and nonbreeding individuals of several estrildid species demonstrate that year-round stability of VT immunoreactivity is found only in highly opportunistic species, and is therefore not essential to the maintenance of long-term pair bonds, which are ubiquitous in the Estrildidae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom